Vertex Pharma (VRTX) volatility at low end of range
Up)
Vertex Pharma (Nasdaq: VRTX) : Vertex Pharma-VRTX closed at $30.71. VRTX, is the developer of telaprevir, a next generation hepatitis drug. VRTX July option implied volatility is at 47; October is at 48; below its 26-week average of 64, according to Track Data, suggesting decreasing price movement. Paul Foster
You May Also Be Interested In
- Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Huntington Bancshares Incorporated
- Activision Blizzard (ATVI) Volatility Rises; Shares at Intraday Lows
- Biosante Pharma (BPAX) Volatility Elevated on Trader Profit Taking
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
